{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:21:44Z","timestamp":1783419704874,"version":"3.54.6"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA148062"],"award-info":[{"award-number":["T32CA148062"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.surg.2021.03.076","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T17:24:30Z","timestamp":1628011470000},"page":"245-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0592-9540","authenticated-orcid":false,"given":"Anna C.","family":"Beck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6368-5217","authenticated-orcid":false,"given":"Anand","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5720-0917","authenticated-orcid":false,"given":"Shannon","family":"Landers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Bellizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7530-8526","authenticated-orcid":false,"given":"Sonia L.","family":"Sugg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3656-2470","authenticated-orcid":false,"given":"Carlos H.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-0793","authenticated-orcid":false,"given":"Ronald J.","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2021.03.076_bib1","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.18632\/oncotarget.14055","article-title":"A\u00a0comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.surg.2021.03.076_bib2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1089\/thy.2012.0563","article-title":"Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis","volume":"23","author":"Kuo","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2021.03.076_bib3","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00268-005-0356-7","article-title":"Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome","volume":"30","author":"Lang","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2021.03.076_bib4","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1089\/thy.2012.0453","article-title":"Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases","volume":"23","author":"Yu","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2021.03.076_bib5","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/cncr.11638","article-title":"c-Met expression in tall cell variant papillary carcinoma of the thyroid","volume":"98","author":"Nardone","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2021.03.076_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12022-018-9561-4","article-title":"Tall cell variant of papillary thyroid carcinoma: impact of change in WHO definition and molecular analysis","volume":"30","author":"Wong","year":"2019","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.surg.2021.03.076_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.surg.2021.03.076_bib8","doi-asserted-by":"crossref","first-page":"e3544","DOI":"10.1371\/journal.pone.0003544","article-title":"In\u00a0vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines","volume":"3","author":"Zito","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.surg.2021.03.076_bib9","doi-asserted-by":"crossref","first-page":"e5395","DOI":"10.1371\/journal.pone.0005395","article-title":"CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin","volume":"4","author":"Friedman","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.surg.2021.03.076_bib10","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.3892\/ol.2016.4936","article-title":"Cancer stem cells as a potential therapeutic target in thyroid carcinoma","volume":"12","author":"Vicari","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.surg.2021.03.076_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fendo.2016.00020","article-title":"Cancer stem cells in the thyroid","volume":"7","author":"Nagayama","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.surg.2021.03.076_bib12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1210\/jc.2010-1255","article-title":"Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid","volume":"96","author":"Malaguarnera","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2021.03.076_bib13","doi-asserted-by":"crossref","first-page":"8874","DOI":"10.1158\/0008-5472.CAN-10-1994","article-title":"Tumorigenic and metastatic activity of human thyroid cancer stem cells","volume":"70","author":"Todaro","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2021.03.076_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00259-012-2242-5","article-title":"CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy","volume":"40","author":"Ke","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.surg.2021.03.076_bib15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.surg.2021.03.076_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.surg.2021.03.076_bib17","article-title":"Rationales for the use of cancer stem cells markers in the staging of papillary thyroid carcinoma","volume":"2019","author":"Mahmood","year":"2019","journal-title":"J\u00a0Oncol"},{"key":"10.1016\/j.surg.2021.03.076_bib18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/107327481502200418","article-title":"Association of cancer stem cell markers with aggressive tumor features in papillary thyroid carcinoma","volume":"22","author":"Lin","year":"2015","journal-title":"Cancer Control"},{"key":"10.1016\/j.surg.2021.03.076_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fendo.2019.00523","article-title":"Immunohistochemical analysis of cancer stem cell marker expression in papillary thyroid cancer","volume":"10","author":"Kim","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.surg.2021.03.076_bib20","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.prp.2017.05.002","article-title":"Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma","volume":"213","author":"Han","year":"2017","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.surg.2021.03.076_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jclinpath-2013-201711","article-title":"Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome","volume":"67","author":"Yun","year":"2014","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.surg.2021.03.076_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182835","article-title":"All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis","volume":"12","author":"Mei","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.surg.2021.03.076_bib23","doi-asserted-by":"crossref","first-page":"e94487","DOI":"10.1371\/journal.pone.0094487","article-title":"Coexpression of EpCAM, CD44 variant isoforms and claudin-7 in anaplastic thyroid carcinoma","volume":"9","author":"Okada","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.surg.2021.03.076_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12020-015-0739-y","article-title":"Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancers","volume":"53","author":"Dima","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.surg.2021.03.076_bib25","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0039-6060(96)80053-5","article-title":"Overexpression of p53 in tall cell variants of papillary thyroid carcinoma","volume":"120","author":"Ruter","year":"1996","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2021.03.076_bib26","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.2147\/CMAR.S167874","article-title":"AP-2alpha expression in papillary thyroid carcinoma predicts tumor progression and poor prognosis","volume":"10","author":"Wu","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.surg.2021.03.076_bib27","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21954","article-title":"Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer","volume":"8","author":"De Andrade","year":"2017","journal-title":"Oncotarget"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003960602100653X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003960602100653X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:59:04Z","timestamp":1758538744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003960602100653X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S003960602100653X"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2021.03.076","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2021.03.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}